Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -69.29%310.33M | -68.66%422.05M | -82.13%507.67M | -76.57%616.38M | -40.86%1.01B | 33.47%1.35B | 200.75%2.84B | 479.17%2.63B | 632.19%1.71B | 934.60%1.01B |
| Transactional financial assets | 17.67%2.02B | 29.38%2B | 44.31%1.97B | 124.25%1.92B | 20.96%1.72B | 46.68%1.55B | 148.57%1.37B | 92.57%858.22M | 206.49%1.42B | 143.17%1.06B |
| Notes receivable and accounts receivable | -23.54%232.18M | -29.77%257.28M | -36.96%258.48M | -65.72%238.45M | -64.68%303.67M | -56.04%366.34M | 9.01%410.04M | 144.54%695.51M | 217.17%859.73M | 200.16%833.35M |
| -Notes receivable | -83.11%2.16M | -90.35%2.54M | 295.58%6.49M | -81.98%3.83M | 133.38%12.78M | 1,260.65%26.31M | -82.15%1.64M | 41.38%21.24M | -49.05%5.48M | -89.13%1.93M |
| -Accounts receivable | -20.92%230.03M | -25.08%254.74M | -38.30%251.99M | -65.20%234.62M | -65.95%290.89M | -59.10%340.02M | 11.29%408.4M | 150.30%674.27M | 228.17%854.25M | 219.98%831.41M |
| Other receivables (including interest and dividends) | 33.69%442.79K | -36.36%210.22K | -21.19%410.56K | -78.85%55.36K | -61.60%331.21K | -38.74%330.34K | -87.57%520.95K | -97.07%261.69K | -81.78%862.59K | -90.19%539.27K |
| -Other receivable | ---- | -36.36%210.22K | ---- | ---- | ---- | -38.74%330.34K | ---- | -94.97%261.69K | ---- | -90.19%539.27K |
| Advance payment | -3.87%132.75M | 64.44%140.53M | 3.80%157.15M | -3.27%88.7M | -15.67%138.1M | -44.87%85.46M | 71.66%151.39M | -17.89%91.7M | 70.79%163.76M | 62.23%155.03M |
| Inventories | 3.23%1.02B | 1.19%990.32M | 6.09%968.96M | 31.57%984.71M | 60.19%984.52M | 84.30%978.69M | 82.25%913.31M | 67.39%748.41M | 60.29%614.62M | 51.26%531.02M |
| Receivable financing | 33.01%80.06M | -43.49%78.54M | -86.71%57.42M | -95.23%44.87M | -96.22%60.19M | -85.76%138.98M | -35.85%432.18M | 65.34%941.36M | 260.41%1.59B | 186.22%975.78M |
| Other current assets | 22.76%77.79M | 33.09%68.75M | -26.78%98.3M | -82.30%75.57M | 373.47%63.37M | 195.32%51.66M | 956.69%134.25M | 3,361.59%426.91M | 44.70%13.38M | -62.34%17.49M |
| Total current assets | -9.50%3.87B | -12.30%3.96B | -35.68%4.02B | -37.85%3.97B | -32.87%4.28B | -1.34%4.52B | 98.36%6.25B | 173.94%6.39B | 234.93%6.38B | 177.65%4.58B |
| Non Current assets | ||||||||||
| Other equity investment | 0.00%79.77M | 39.95%79.77M | 39.95%79.77M | 83.38%79.77M | 298.84%79.77M | 185.00%57M | 185.00%57M | 117.50%43.5M | 0.00%20M | 0.00%20M |
| Other non-current financial assets | -66.88%33.89M | -63.60%33.89M | -68.37%32.65M | -75.65%32.79M | -27.31%102.33M | -44.78%93.11M | -31.28%103.22M | -5.65%134.68M | 59.38%140.79M | 90.88%168.61M |
| Investment real estate | -4.70%3.37M | -4.65%3.41M | -4.59%3.46M | -4.54%3.5M | -3.68%3.54M | -3.91%3.58M | -4.13%3.62M | -4.34%3.66M | -4.33%3.67M | -4.27%3.73M |
| Long-term equity investment | -6.00%31.73M | 5.89%31.11M | 2.18%30.06M | 1.71%29.98M | 53.38%33.76M | 24.44%29.38M | 33.41%29.42M | 37.04%29.48M | -14.28%22.01M | -2.58%23.61M |
| Fixed assets | ---- | 34.93%1.57B | ---- | ---- | ---- | 36.04%1.16B | ---- | 27.95%1.08B | ---- | 23.43%856.27M |
| Constru in process | ---- | -45.85%281.83M | ---- | ---- | ---- | 76.65%520.43M | ---- | 552.25%462.39M | ---- | 179.34%294.61M |
| Intangible assets | -2.48%143.05M | -2.41%144.12M | -2.78%144.54M | -2.74%145.56M | 14.43%146.69M | 14.42%147.68M | 27.54%148.67M | 53.09%149.66M | 30.17%128.18M | 30.12%129.06M |
| Goodwill | -34.82%34.89M | -34.82%34.89M | -34.82%34.89M | -34.82%34.89M | 0.00%53.52M | 0.00%53.52M | 0.00%53.52M | 0.00%53.52M | -0.23%53.52M | -0.23%53.52M |
| Long deferred expense | ---- | ---- | ---- | ---- | -91.17%232.3K | 50.97%829.51K | 120.10%1.47M | 128.58%1.94M | 236.05%2.63M | -42.86%549.44K |
| Deferred tax assets | 5.14%11.81M | 39.52%11.03M | 44.08%10.88M | -4.32%9.41M | -3.16%11.23M | -26.26%7.9M | 18.14%7.55M | 57.23%9.84M | 104.33%11.6M | 90.68%10.72M |
| Usufruct assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -84.62%159.77K | -75.00%319.54K |
| Other non current assets | 1,177.49%42.45M | -46.42%3.91M | -47.45%7.06M | -65.93%9.4M | -95.36%3.32M | -84.11%7.29M | -75.88%13.44M | -68.18%27.6M | 346.41%71.59M | 227.36%45.87M |
| Total non current assets | 1.91%2.23B | 5.28%2.2B | 8.21%2.17B | 7.61%2.15B | 26.78%2.19B | 29.79%2.09B | 36.21%2.01B | 47.94%2B | 47.58%1.73B | 44.72%1.61B |
| Total assets | -5.64%6.11B | -6.75%6.16B | -25.01%6.19B | -27.01%6.13B | -20.15%6.47B | 6.75%6.6B | 78.56%8.26B | 127.72%8.39B | 163.60%8.1B | 124.15%6.18B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Notes payable and accounts payable | 0.89%154.52M | 35.32%238M | 26.68%210.64M | -36.35%186.01M | 6.79%153.16M | 46.32%175.88M | 12.86%166.28M | 138.69%292.25M | 47.95%143.41M | 43.39%120.2M |
| -Notes payable | --8.14M | --93.98M | --92.66M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Accounts payable | -4.42%146.39M | -18.11%144.02M | -29.04%117.98M | -36.35%186.01M | 6.79%153.16M | 46.32%175.88M | 12.86%166.28M | 138.69%292.25M | 47.95%143.41M | 43.39%120.2M |
| Contract liabilities | -21.83%37.56M | -56.96%40.54M | -68.76%44.23M | -72.52%47.5M | -79.90%48.05M | -45.10%94.2M | 39.60%141.58M | 56.45%172.85M | 267.98%239.1M | 242.39%171.58M |
| Salaries payable | -5.48%14.42M | -8.38%14.91M | -26.46%14.97M | -57.65%14.97M | -56.34%15.26M | -47.92%16.28M | 34.61%20.36M | 137.71%35.35M | 219.25%34.95M | 186.65%31.25M |
| Taxs payable | -63.60%7.17M | -82.92%3.68M | -61.27%8.94M | -88.05%18.49M | -95.40%19.69M | -94.48%21.53M | -88.35%23.09M | 49.21%154.7M | 543.06%428.1M | 624.56%389.82M |
| Other payable (including interest and dividends) | -98.47%5.57M | -99.83%775.11K | -99.30%758.6K | -99.16%909.48K | 12,893.00%363.59M | 17,981.69%467.82M | 4,319.93%108.01M | 4,028.26%107.65M | 10.23%2.8M | 3.66%2.59M |
| -Dividend payable | ---- | ---- | ---- | ---- | --357.34M | --467.34M | --106.59M | --106.59M | ---- | ---- |
| -Other payable | ---- | 60.84%775.11K | ---- | ---- | ---- | -81.37%481.91K | ---- | -59.28%1.06M | ---- | 3.66%2.59M |
| Non current liabilities due within one year | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -77.21%291.12K | -64.80%449.73K |
| Other current liabilities | -64.74%5.73M | -69.99%6.1M | -53.25%9.22M | -56.42%8.87M | -51.69%16.24M | -6.71%20.31M | 40.62%19.72M | 45.80%20.35M | 359.54%33.62M | 124.50%21.77M |
| Total current liabilities | -63.48%224.97M | -61.81%304M | -39.72%288.76M | -64.66%276.75M | -30.18%615.99M | 7.91%796.03M | -0.26%479.04M | 112.28%783.14M | 252.12%882.27M | 239.77%737.66M |
| Current liabilities | ||||||||||
| Deferred tax liabilities | -4.01%25.62M | 14.43%23.94M | 2.64%22.03M | -3.78%21.06M | 25.19%26.69M | -13.01%20.92M | 6.08%21.46M | 17.48%21.88M | 105.52%21.32M | 128.82%24.05M |
| Long term deferred income | -49.00%25.14M | -41.67%26M | 29.17%28.11M | 23.63%27.74M | 315.48%49.29M | 259.03%44.57M | 67.84%21.76M | 65.58%22.44M | -16.10%11.86M | -15.73%12.41M |
| Total non current liabilities | -33.20%50.76M | -23.75%49.94M | 16.00%50.14M | 10.10%48.8M | 128.97%75.98M | 79.61%65.49M | 30.20%43.23M | 37.74%44.32M | 35.36%33.18M | -61.32%36.46M |
| Total liabilities | -60.15%275.72M | -58.92%353.94M | -35.11%338.91M | -60.66%325.54M | -24.41%691.97M | 11.29%861.51M | 1.71%522.27M | 106.30%827.46M | 232.80%915.45M | 148.61%774.13M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%541.68M | 0.00%541.68M | 49.93%541.68M | 49.93%541.68M | 49.93%541.68M | 49.93%541.68M | 0.00%361.28M | 0.00%361.28M | 0.00%361.28M | 1.34%361.28M |
| Capital reserve funds | 0.00%673.75M | 0.00%673.75M | -21.12%673.75M | -21.12%673.75M | -21.12%673.75M | -21.12%673.75M | 0.00%854.15M | 0.00%854.15M | 0.00%854.15M | 9.67%854.15M |
| Surplus reserve funds | 0.00%734.1M | 0.00%734.1M | 0.00%734.1M | 0.00%734.1M | 205.14%734.1M | 205.14%734.1M | 205.14%734.1M | 205.14%734.1M | 73.58%240.58M | 73.58%240.58M |
| Retained profit | 1.48%3.9B | 2.23%3.87B | -31.77%3.92B | -30.55%3.87B | -32.57%3.84B | -3.48%3.79B | 118.51%5.74B | 207.94%5.57B | 299.17%5.7B | 242.20%3.92B |
| Less:Treasury stock | 0.00%106.62M | 48.37%106.62M | 186.53%106.62M | 1,116.80%106.62M | --106.62M | --71.86M | --37.21M | --8.76M | ---- | ---- |
| Other composite income | -0.10%56.47M | 51.90%56.47M | 51.90%56.47M | 182.70%56.47M | --56.53M | --37.18M | --37.18M | --19.98M | ---- | ---- |
| Shareholders equity without minority interests | 0.99%5.8B | 1.21%5.77B | -24.37%5.82B | -23.41%5.77B | -19.75%5.74B | 5.99%5.7B | 88.35%7.69B | 130.65%7.53B | 157.22%7.16B | 121.21%5.38B |
| Minority interests | -15.04%30.81M | -17.94%31.47M | -15.23%32.74M | -7.50%33.93M | 9.89%36.26M | 25.14%38.36M | 56.77%38.62M | 79.74%36.69M | 89.69%33M | 94.18%30.65M |
| Total shareholder equity | 0.89%5.83B | 1.08%5.8B | -24.33%5.85B | -23.33%5.8B | -19.61%5.78B | 6.10%5.74B | 88.16%7.73B | 130.33%7.57B | 156.80%7.19B | 121.04%5.41B |
| Total liabilityies and equity | -5.64%6.11B | -6.75%6.16B | -25.01%6.19B | -27.01%6.13B | -20.15%6.47B | 6.75%6.6B | 78.56%8.26B | 127.72%8.39B | 163.60%8.1B | 124.15%6.18B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.